Theramyt Novobiologics Private Limited, a dissolved under section 59(8) private limited company, was established on 22 July 2013 in Bangalore, Karnataka, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U73100KA2013PTC070233. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹6.64 M and a paid-up capital of ₹4.94 M.
It upholds a compliant status. Employing 3 professional, Its leadership includes Anirban Bhattacharya (Director), Kavitha Iyer Rodrigues (Director). Past directors included Sohang Chatterjee, Ranjith Menon, Anirban Bhattacharya. Its latest AGM occurred on 28 June 2019, with the balance sheet filed on 31 March 2019. It is based at Prasad Enclave,118/119, Ground Floor, Yeshwanthpur Industrial Suburb Ii Stage, 5Th Main,Yes, Hwanthpur, Bangalore, Karnataka, 560022.
U73100KA2013PTC070233
070233
22 July 2013
₹6.64 M
₹4.94 M
Roc Bangalore
Unlisted
Dissolved Under Section 59(8)
Explore comprehensive insights into Theramyt Novobiologics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anirban Bhattacharya | Director | 01 Oct 2016 | Current |
| Kavitha Iyer Rodrigues | Director | 22 Jul 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Aug 2013 | Past |
| Pramod Abcsdd | Nominee Director | 03 Dec 2019 | Past |
| Pramod Abcsdd | Company Secretary | 30 Sep 2016 | Past |
| Pramod Abcsdd | Nominee Director | 03 Dec 2019 | Past |
| Pramod Abcsdd | Whole-Time Director | 08 Oct 2015 | Past |
| Pramod Abcsdd | Nominee Director | 02 Dec 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Theramyt Novobiologics Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 329.14% increase. The company also saw a substantial improvement in profitability, with a 87.37% increase in profit. The company's net worth dipped by a decrease of 0.91%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Theramyt Novobiologics had a promoter holding of 97.76% and a public holding of 2.24%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Theramyt Novobiologics has a workforce of 3 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Theramyt Novobiologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Theramyt Novobiologics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Theramyt Novobiologics Private Limited last Annual general meeting of members was held on 28 Jun 2019 as per latest MCA records. was completed.
Theramyt Novobiologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Bangalore. was recorded as a recent event.
Anirban Bhattacharya was appointed as a Director was appointed as a Director on 01 Oct 2016 & has been associated with this company since 9 years 3 months . was recorded as a recent event.
Progress on Kavitha Iyer Rodrigues was appointed as a Director was appointed as a Director on 22 Jul 2013 & has been associated with this company since 12 years 5 months . was documented.
The activity Theramyt Novobiologics Private Limited was registered on 22 Jul 2013 with Roc Bangalore & aged 12 years 5 months as per MCA records. was completed.
The CIN of Theramyt Novobiologics Private Limited is U73100KA2013PTC070233.
Theramyt Novobiologics Private Limited is headquartered at Prasad Enclave,118/119, Ground Floor, Yeshwanthpur Industrial Suburb Ii Stage, 5Th Main,Yes, Hwanthpur, Bangalore, Karnataka, 560022.
Theramyt Novobiologics Private Limited was incorporated on 22 July 2013.
The current directors of Theramyt Novobiologics Private Limited are
The primary industry of Theramyt Novobiologics Private Limited is Professional, Scientific And Technical.
Theramyt Novobiologics Private Limited is unlisted.
The authorized capital of Theramyt Novobiologics Private Limited is ₹6.64 M, and the paid-up capital is ₹4.94 M.
The compliance status of Theramyt Novobiologics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX